ITOC12 – Programme Now Online!

Submit Your Abstract & Register Early

Dear colleagues,

We are pleased to announce that the invited programme for the 12th ImmunoTherapy of Cancer Conference (ITOC12) is now finalized and available online!

📄 View the programme here: https://www.itoc-conference.eu/programme

The ITOC12 will bring together leading international experts to discuss the latest advances in cancer immunotherapy – from basic research to clinical application.

Now it’s your turn to contribute to the scientific programme!

We warmly invite you to submit your abstract for consideration as an oral or poster presentation and share your latest research and findings with the ITOC community.

🧬 Abstract submission deadline: January 5, 2026

💡 Don’t miss this opportunity to present your work to an engaged audience of clinicians, scientists, and industry professionals.

In addition, we encourage you to take advantage of the early registration discount – available until February 2, 2026.

Secure your spot early and save on your registration fee!

Join us at ITOC12 and be part of one of the most dynamic forums dedicated to advancing cancer immunotherapy.

We look forward to your contributions and to welcoming you in person!

Best regards,

The ITOC12 Organizing Committee

www.itoc-conference.eu

________________________________________

Submission Topics:

• Tumor Immunology

• Mode of action of Immune Therapies

• New Targets and New Leads

• Immunooncology in gynecological cancers

• Polyspecific Antibody Derivatives

• Immune Monitoring – Omics Technology

• Cancer Vaccines

• Young Researcher Session

• Cellular Therapies (including combinations)

We herewith invite you to visit the WEBSITE for more information on the conference